Cite
HARVARD Citation
Osorio, D. et al. (n.d.). Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma. Pediatric blood & cancer. 60 (9), pp. E100-E102. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Osorio, D. et al. (n.d.). Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma. Pediatric blood & cancer. 60 (9), pp. E100-E102. [Online].